Dual serotonin and noradrenaline uptake inhibitor class of anti-depressants - Potential for greater efficacy or just hype?

Progress in Drug Research

Volumn 58, Issue , 2002, Pages 169-222

  Wong, David T ^a   Bymaster, Frank P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Depression; Dopamine; Dual uptake inhibitors; Duloxetine; Fluoxetine; Milnacipran; Norepinephrine; Serotonin; Serotonin selective reuptake inhibitors; SSRI; Tricyclic antidepressants; Venlafaxine

Indexed keywords

AMITRIPTYLINE; ATOMOXETINE; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DULOXETINE; FLUOXETINE; FLUVOXAMINE; IDAZOXAN; IMIPRAMINE; INDALPINE; ION CHANNEL; MILNACIPRAN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NISOXETINE; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PINDOLOL; PRAZOSIN; REBOXETINE; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; ENZYME ACTIVITY; GUINEA PIG; HUMAN; MICRODIALYSIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SECOND MESSENGER;

EID: 0036236178     PISSN: 0071786X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0348-8183-8_5     Document Type: Review

References (147)

1. The role of norepinephrine in the treatment of depression. (Academic Highlights)